Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Guessing Game
View:
Post by Pareto8020 on Jul 06, 2022 10:22am

Guessing Game

In the absence of any real info about their Allergan deal we are once again left to ponder figures on our own.

Linda Pullman's recent tweet/post indicated the median upfront payment was $54M.  I'm assuming that is USD so apply a modest exchange rate that would still be several millions more than Sirona's market cap.  Even if you assume they got half the median that is still a big chunk of change relative to their market cap.  And what would that do to the share price if revealed?  Never mind the $680M that PRC is forecasting in royalty payments!  

They really missed an opportunity to finally get the share price reflecting the value of their technology.

Comment by biorun on Jul 06, 2022 1:07pm
Does the share price not point to an entry point? I called it at various levels and turned out to be correct about 80% of time, and 100% accurate when it gets this stupid. It is super stupid right now. I am certain these prices below 25 cents will not last. A squeeze is imminent. You will see. do your own due diligence, I am not a certified investment advisor. lmfao.
Comment by navajojoe on Dec 09, 2022 4:22pm
This post has been removed in accordance with Community Policy
Comment by biorun on Dec 09, 2022 4:42pm
yes my good buddy, just after that it ran to 35 cents.
Comment by navajojoe on Dec 09, 2022 6:07pm
This post has been removed in accordance with Community Policy
Comment by MirrorWorldMan on Jul 06, 2022 2:05pm
Other than Howies giddiness, there are no clues to any monetary value on this deal. He was self excited often before in previous anticipations that turned bust. So his interpretations mean nothing.  But we are stuck with this guy who will not walk away, and must wait until revenue is reported somewhere. We do not even know what year a product will be introduced into the market, much less size ...more  
Comment by biorun on Jul 06, 2022 2:27pm
The numbers are there, but we haven't seen them (yet). Just because you can't see past the horizon at tonights sunset doesn't mean that the world is FLAT. The company just signed the biggest deal in its history but it can't disclose the details yet. My sense is that the royalties and associated global rollout is really the banger here, that is the bigger revenue stream on a ...more  
Comment by Pareto8020 on Jul 06, 2022 2:33pm
I vividly remember during one of Howard's infamous video interviews that he said if exclusive rights were granted to a company that it would require a substantial payout for that exclusivity.  Wonder if he followed through on that premise and exacted a hefty upfront? Given all they have planned as far a restructuring and clinical trials, etc.  it gives the impression that they now ...more  
Comment by lscfa on Jul 06, 2022 4:33pm
Mgmt could be making all these big plans based on a modest upfront payment of say $2 million and guidance from Abbvie as to when the 1st milestone may be reached triggering another payment of $3 million in 12 months. 
Comment by navajojoe on Jul 06, 2022 5:48pm
This post has been removed in accordance with Community Policy
Comment by Tickel1st on Jul 06, 2022 7:13pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse